Abstract
Purpose:
Spontaneous resolution of vitreomacular traction syndrome in diabetic patients is a rare phenomenon that has been poorly described in the literature.
Methods:
Case presentation.
Results:
The authors present a case of spontaneous resolution of vitreomacular traction following intravitreal administration of ranibizumab.
Conclusions:
In patients with vitreomacular traction syndrome and diabetic macular edema, the combination of the possible vitreous liquefaction and mechanical increase of vitreous volume caused by an intravitreal injection with a degree of reduction in retinal thickness caused by the effect of vascular endothelial growth factor inhibition could play a role in the resolution of vitreomacular traction.
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / administration & dosage*
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Diabetic Retinopathy / complications
-
Eye Diseases / diagnosis
-
Eye Diseases / drug therapy*
-
Fluorescein Angiography
-
Humans
-
Injections
-
Macular Edema / diagnosis
-
Macular Edema / drug therapy
-
Macular Edema / etiology
-
Male
-
Ranibizumab
-
Remission, Spontaneous
-
Retinal Diseases / diagnosis
-
Retinal Diseases / drug therapy*
-
Syndrome
-
Tissue Adhesions / diagnosis
-
Tissue Adhesions / drug therapy
-
Tomography, Optical Coherence
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vitreous Body / drug effects*
-
Vitreous Body / pathology
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Ranibizumab